Sarah James
Stock Analyst at Cantor Fitzgerald
(2.10)
# 2,727
Out of 4,778 analysts
277
Total ratings
32.71%
Success rate
-3.89%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintains: Overweight | $350 → $365 | $316.54 | +15.31% | 21 | Mar 20, 2025 | |
| TBRG TruBridge | Maintains: Overweight | $20 → $29 | $29.00 | - | 6 | Mar 11, 2025 | |
| LFMD LifeMD | Reiterates: Overweight | $15 | $6.00 | +150.21% | 11 | Mar 11, 2025 | |
| THC Tenet Healthcare | Reiterates: Overweight | $177 | $130.82 | +35.30% | 20 | Feb 13, 2025 | |
| HUM Humana | Reiterates: Neutral | $290 | $273.99 | +5.84% | 20 | Feb 12, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $405 | $336.38 | +20.40% | 19 | Jan 27, 2025 | |
| ELV Elevance Health | Reiterates: Overweight | $485 | $423.64 | +14.48% | 19 | Jan 24, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $700 | $513.45 | +36.33% | 17 | Jan 17, 2025 | |
| CNC Centene | Reiterates: Overweight | $90 | $58.94 | +52.70% | 12 | Dec 11, 2024 | |
| ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $28.79 | +80.62% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $17 | $21.50 | -20.91% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $219 | $185.92 | +17.79% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $310.53 | +30.74% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $24.21 | +77.61% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $4.48 | +257.14% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $66.51 | -6.77% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $2.81 | +77.94% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $8.65 | +15.67% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $92.36 | +9.35% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $150.78 | -11.79% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $17.11 | +145.47% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $2.99 | +67.22% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $5.51 | -9.26% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $17.59 | +19.39% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $50.71 | -23.09% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $69.37 | +178.22% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.81 | - | 2 | Mar 1, 2017 |
The Cigna Group
Mar 20, 2025
Maintains: Overweight
Price Target: $350 → $365
Current: $316.54
Upside: +15.31%
TruBridge
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $29.00
Upside: -
LifeMD
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $6.00
Upside: +150.21%
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $130.82
Upside: +35.30%
Humana
Feb 12, 2025
Reiterates: Neutral
Price Target: $290
Current: $273.99
Upside: +5.84%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $336.38
Upside: +20.40%
Elevance Health
Jan 24, 2025
Reiterates: Overweight
Price Target: $485
Current: $423.64
Upside: +14.48%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $513.45
Upside: +36.33%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $58.94
Upside: +52.70%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $28.79
Upside: +80.62%
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $21.50
Upside: -20.91%
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $185.92
Upside: +17.79%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $310.53
Upside: +30.74%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $24.21
Upside: +77.61%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $4.48
Upside: +257.14%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $66.51
Upside: -6.77%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $2.81
Upside: +77.94%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $8.65
Upside: +15.67%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $92.36
Upside: +9.35%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $150.78
Upside: -11.79%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $17.11
Upside: +145.47%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $2.99
Upside: +67.22%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $5.51
Upside: -9.26%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $17.59
Upside: +19.39%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $50.71
Upside: -23.09%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $69.37
Upside: +178.22%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.81
Upside: -